The Case for Layered Protocol Design
Single-compound research answers a single mechanistic question. Multi-compound protocol research asks a different kind of question: how do multiple non-overlapping pathways interact when engaged simultaneously?
The 5-layer protocol design addresses this by selecting compounds that cover distinct receptor pathways with minimal mechanism overlap — enabling research that no single compound can support.
Layer 1: GLP Core
Primary compound: GLP-3 R (Retatrutide) Mechanism: Tri-receptor (GLP-1R, GIPR, GcgR) Research focus: Metabolic recomposition — energy balance, appetite regulation, body composition
Retatrutide is the primary study compound because it produces the strongest signal in its class. The Phase 2 −28.7% at 48 weeks is the most compelling single-compound GLP result in current literature.
The GLP core establishes the metabolic research baseline. All other layers are adjunct to this primary axis.
Layer 2: Gut Recovery
Compounds: BPC-157 + GLP-2 T Mechanisms: NO system/VEGFR2 (BPC-157), GLP-2R epithelial trophism (GLP-2 T) Research focus: GI mucosal integrity during GLP-core protocol
The rationale for Layer 2 follows from Layer 1: GLP receptor agonists reduce gastric motility and caloric throughput. Investigating how GI mucosal integrity responds to this environment — and whether it can be supported by gut-targeted compounds — is a natural research extension.
BPC-157 and GLP-2 T address this through complementary, non-overlapping mechanisms. BPC-157 targets the NO system and direct mucosal protection. GLP-2 T targets GLP-2R epithelial proliferation. Using both covers the maximum research breadth for this layer.
Layer 3: Skin & Glow
Compounds: GHK-Cu + SNAP-8 Mechanisms: Gene expression/collagen matrix (GHK-Cu), SNARE complex/NMJ (SNAP-8) Research focus: Integumentary tissue response during metabolic recomposition
Body composition changes affect skin tissue — collagen architecture, dermal thickness, and expression line dynamics are all relevant outcome areas in the context of significant body composition shifts.
GHK-Cu (4,000+ gene interactions, primarily collagen/elastin upregulation) and SNAP-8 (SNARE complex interaction for NMJ research) cover the two primary skin research pathways.
Layer 4: Lean Mass
Compounds: CJC-1295/Ipamorelin + IGF-1 LR3 Mechanisms: GHRH receptor + GHS-R1a (CJC/Ipa), IGF-1R (IGF-1 LR3) Research focus: GH axis activation during caloric restriction phase
GLP-based protocols reduce caloric intake. In this context, GH axis research asks: how does the somatotropic axis respond, and can GH axis activation support lean mass maintenance during energetic deficit? CJC-1295/Ipamorelin targets pulsatile GH secretion; IGF-1 LR3 addresses downstream GH signaling through the IGF-1 receptor.
Layer 5: Longevity
Compounds: Epithalon + NAD+ Mechanisms: Telomerase activation (Epithalon), sirtuin/PARP substrate (NAD+) Research focus: Cellular aging mechanisms during protocol
Epithalon and NAD+ address cellular aging from two angles: telomere biology and cellular energy metabolism. Their mechanism of action is entirely distinct from all other protocol layers — no receptor overlap, no pathway competition.
Protocol Structure Principles
- Non-overlapping mechanisms: Each layer should target a distinct receptor or pathway family. Mechanism overlap creates confounding variables without additional research benefit.
2. Hierarchical priority: The GLP core is primary; all other layers are adjunct. This allows independent analysis of primary vs adjunct compound effects.
3. Tier your entry: Not every research design requires all 5 layers simultaneously. Start with Layer 1 (GLP core) and add layers iteratively as research questions expand.
4. HPLC purity standardization: Use >98% HPLC purity compounds across all layers. Variable purity across compounds introduces impurity confounders that make multi-compound data harder to interpret.